- Report
- April 2025
- 50 Pages
Global
From €2417EUR$2,650USD£2,066GBP
Nilvadipine is a calcium channel blocker used to treat hypertension and angina. It is a cardiovascular drug that works by relaxing the blood vessels, allowing blood to flow more easily and reducing the workload on the heart. It is also used to prevent stroke and heart attack. Nilvadipine is available in both oral and intravenous forms. It is generally well tolerated, with few side effects.
Nilvadipine is a widely used drug in the cardiovascular market. It is prescribed by doctors to treat hypertension, angina, and other cardiovascular conditions. It is also used to prevent stroke and heart attack. It is available in both oral and intravenous forms, making it a convenient option for patients.
The Nilvadipine market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include Pfizer, Novartis, Sanofi, Merck, and GlaxoSmithKline. Other companies such as Mylan, Teva, and Sun Pharmaceuticals also offer Nilvadipine. Show Less Read more